Introduction
Brain lesions in deep-seated locations present a surgical challenge. [1] [2] [3] [4] In certain situations, extensive surgical resection is not considered appropriate either because resection may not alter the natural history of the disease or may not be possible without causing significant morbidity. [1] [2] [3] [4] However, obtaining tissue for diagnosis is often necessary to guide potential adjuvant therapies including radiation and chemotherapy. [1] [2] [3] [4] The typical approach for obtaining tissue for these lesions involves either burr hole needle biopsies or open biopsies through craniotomies. [1] [2] [3] [4] Needle biopsies
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Abstract
Background and Study Aims/Objective Brain lesions in deep-seated locations can present a surgical challenge. Tissue remains the gold standard for diagnosing these lesions to guide potential adjuvant therapy. These lesions have been traditionally approached by stereotactic needle biopsy, open biopsies through craniotomies, and excisional biopsies. We provide a safe alternative method using tubular retractors under exoscopic visualization for biopsies of deep-seated brain lesions.
Material and Methods
All patients who underwent a biopsy with the use of a tubular retractor under exoscopic visualization of a deep-seated lesion from January 2013 to September 2016 were identified prospectively and followed. This was done for patients with lesions where extensive resection was not deemed possible because of eloquent location and/or lack of impact on the natural history of the disease. Results A total of 11 patients, with an average age (plus or minus standard deviation) of 48.7 AE 18.3 years, underwent biopsies with tubular retractors and exoscopic visualization. The locations included thalamus (n ¼ 3), optic pathway (n ¼ 2), deep cerebellar nuclei (n ¼ 1), centrum semiovale/corpus callosum (n ¼ 4), and multifocal (n ¼ 2). Diagnosis was obtained in all patients: glioblastoma multiforme (n ¼ 3), anaplastic astrocytoma (n ¼ 3), demyelinating disease (n ¼ 2), renal cell cancer (n ¼ 1), and lymphoma (n ¼ 2). In all cases with tumors, the molecular analyses were conducted successfully. On postoperative computed tomography, no patients had notable hematomas and no patients had new deficits. Conclusion Diagnosing brain lesions is critical for guiding potential adjuvant therapies. When surgical resection is not possible or required, we report the efficacy of a tubular retractor system with exoscopic visualization for the safe access of deep-seated lesions to provide adequate tissue for diagnosis and molecular evaluation.
provide a scant amount of tissue, making it difficult to establish pathologic diagnoses. [5] [6] [7] [8] [9] [10] Moreover, this lack of tissue often precludes molecular studies and tissue banking for further testing.
5-10
For deep-seated lesions, open biopsies through craniotomies require larger openings and have a similar risk profile to craniotomies aiming to achieve extensive resection.
11,12
We present an alternative minimally invasive technique for performing biopsies via small craniotomies using tubular retractors under exoscopic visualization with the use of an extracorporeal scope. This technique has the advantage of supplying sufficient tissue for diagnosis and further testing, and it may be an alternative to traditional burr hole needle biopsies and open biopsies through craniotomies.
Materials and Methods
Institutional approval was obtained prior to the start of this study (no. 72892).
Patient Selection
All patients who underwent biopsy using minimally invasive surgery with the use of a tubular retractor under exoscopic visualization from January 2013 to September 2016 by the senior authors (K.C. and G.G.) were identified prospectively. This included lesions located in deep-seated areas that include basal ganglia, thalamus, cerebellar peduncles, and hippocampal regions, where extensive resection was not deemed possible because of eloquent location and/or lack of impact on the natural history of the disease. Biopsies were defined as planned subtotal resection of the selected lesion or resection of one lesion in the case of multiple brain lesions. These patients were identified prospectively, and recorded variables included age, gender, tumor location, tumor size, preoperative neurologic function, specimen size, postoperative hematoma (significant being more than punctate), postoperative neurologic function, and follow-up time.
General Treatment Strategy
Patients who presented with deep-seated lesions where a diagnosis was needed and extensive resection was not deemed appropriate either because of surgical morbidity and/or the effects of surgical resection would not change the natural history of the lesion were considered candidates for this approach (►Figs. 1 and 2). Patients would undergo preoperative magnetic resonance imaging (MRI) 1 to 2 days before surgery. For basal ganglia and thalamic lesions, diffusion tensor images were also typically obtained to understand the location of critical white matter tracts. The trajectory toward the lesion was planned ahead of time and based on causing the least amount of surgical morbidity and avoiding critical white matter tracts. A trans-sulcal route was typically preferred to minimize the amount of injury to the brain parenchyma and to avoid injuring critical white matter tracts.
A linear incision measuring 2 to 3 cm was typically done over the planned trajectory based on navigation guidance (Brainlab, Westchester, Illinois, United States) (►Fig. 1B). A high-speed drill equipped with a perforator was used to make a burr hole, and a craniotome was used to perform a craniotomy measuring $ 3 cm in diameter (►Fig. 1B). The dura was then opened in a cruciate fashion measuring $ 1 Â 1 cm overlying the desired sulcus (►Fig. 1C). A 0-or 90-degree exoscope (VITOM; Karl Storz, El Segundo, California, United States) attached to a pneumatic arm (UniArm; Mitaka, Park City, Utah, United States) was used to provide visualization and magnification to open the desired sulcus. Under navigation guidance, a preselected tubular retractor with cannula (BrainPath; NICO, Indianapolis, Indiana, United States) of the desired length to reach the superficial surface of the lesion was passed through the sulcus (►Fig. 1D).
Once the superficial surface of the lesion was reached, the internal cannula was removed and the exoscope provided visualization (►Fig. 1E). An exoscopic view is visualization with the use of a scope external to the body. This contrasts with an endoscopic view where visualization is obtained by placing a scope inside the body (i.e., through the nose, into the brain, etc.) (►Fig. 3). Specimens were then obtained using tumor forceps and/or a side-biting tissue aspiration device (Myriad; NICO). Depending on how much tissue was needed and the location of the tissue, more specimen was obtained and/or the retractor was moved to a different location to obtain more tissue. In circumstances where it was unclear if the retractor was in the desired location, an ultrasound probe (Hitachi Aloka, Wallingford, Connecticut, USA) was passed through the retractor to confirm location. The amount of specimen provided to pathology was measured by the pathologist when placed on a slide prior to freezing.
After resection, the retractor was slowly withdrawn (►Fig. 2D). Irrigation was used in the cavity to confirm hemostasis. The dura was then closed primarily. The bone flap was replaced with titanium plates. The galea and scalp were closed in standard fashion. Postoperative head computed tomography (CT) was then performed to evaluate unexpected postoperative changes (►Figs. 1F and 2E). The patient were observed in the critical care unit overnight and typically discharged on postoperative day 1.
Results
Eleven patients underwent minimally invasive surgery for biopsies using tubular retractors with exoscopic guidance for deep-seated brain lesions from January 2013 to September 2016 (►Table 1). Six were male and five were female, with an average age (plus or minus standard deviation [SD]) of 48.7 AE 18.3 years. The locations included thalamus in three, optic pathway in two, deep cerebellar nuclei in one, centrum semiovale/corpus callosum in four, and multifocal in two. Four of these patients underwent surgery because there was concern about tumor versus demyelinating/inflammatory disorder, one underwent surgery to evaluate recurrent tumor versus treatment effect for glioblastoma multiforme, and two had presumed lymphoma.
Preoperatively, five patients presented with weakness, four with headaches, two with seizures, and two with vision [1] [2] [3] [4] Moreover, the lack of direct visualization can make it difficult to confirm hemostasis and stop potential bleeding during these procedures, where postoperative bleeding has been reported in up to 9% of stereotactic biopsies. [5] [6] [7] [8] [9] [10] Open biopsies through craniotomies require larger openings than stereotactic biopsies.
11,12
Although they can provide a relatively large sample size for pathologic diagnosis, open biopsies for deep-seated lesions are associated with higher rates of surgery-related morbidities due to the need for larger tissue exposure, prolonged retraction of surrounding brain tissue, and more dissection of critical white matter tracts.
11,12 As compared with needle biopsies, open biopsies are more frequently associated with cerebral edema, infarction, and hemorrhagic Fig. 3 The surgical setup. The exoscope is suspended over the surgical field attached to a pneumatic arm. The tubular retractor is attached to a fixed retractor system.
transformation.
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The rates of intracranial hemorrhage vary from 7% to 30% and postoperative seizures in 10 to 20% of open biopsies.
Tubular retractor systems were designed to provide access to deep corridors while limiting associated risks. [16] [17] [18] [19] [20] [21] However, these earlier versions were limited due to the bulk and lack of transparency of the metal or hard plastic retractors. [16] [17] [18] [19] [20] [21] Furthermore, the fixed nature of frame-based stereotactic navigation system was cumbersome and limited the flexibility of the operative field. [16] [17] [18] [19] [20] [21] The system used in this study was a transparent plastic tubular retractor with a diameter that provides safe displacement of white matter tracts. 22, 23 The use of an exoscope, or an extracorporeal scope, provided optimum visualization through this transparent retractor system. 22, 23 This is different than an endoscope because it is placed above the surgical field outside of the surgical cavity, whereas an endoscope is placed within the cavity. By being above the surgical field, an exoscope allows bimanual manipulation, no need to hold the scope because it is attached to a pneumatic arm, and it does not reduce the working corridor. In addition, an exoscope, as compared with a microscope, provides more operative flexibility and degrees of visualization by having smaller optics, higher magnification ability, and more maneuverability. 22, 23 The retractor itself has a 13.5-mm diameter and its length varies. It has an obturator insert that is gradually tapered and designed to displace, rather than severe, white matter tracts. 22, 23 Traditionally, this has been used for intraparenchymal clot evacuation. [23] [24] [25] More recently, it was also used to resect intraand periventricular lesions in a multicenter study 22 and for the treatment of ruptured aneurysms, arteriovenous malformations, and cavernomas in case reports. 24, 26 We have expanded the use of this system for biopsies of deep-seated brain lesions. Our study is the first to describe the use of this technique for accessing deep-seated lesions for biopsies. It provides an alternative to typical burr hole-based needle biopsies and open biopsies through standard craniotomies. The retractor allows safe displacement of critical white matter tracts, and no patients in this study had new deficits. The retractor also provides a corridor for obtaining sufficient tissue for pathologic examinations. The exoscope provides a similar magnification profile as surgical microscopes and allows adequate visualization for lesions located several centimeters away from the surface. Diagnosis was obtained in all cases, and sufficient tissue was available for molecular analyses and tissue banking. In addition, bleeding can be identified and addressed after the retractor is placed and removed. No patients had significant postoperative hemorrhage. Our study is not without limitations. Patients selected for this technique were subject to bias because they were chosen selectively for this technique. It is not indicated for all deep-seated lesions but can provide an alternative to traditional methods. The study also was not designed to compare this approach with needle biopsies and/or open biopsy techniques. The gold standard would be to do a randomized study comparing different techniques. However, the main goal of this study was to provide proof of principle for the efficacy of this technique with tubular retractors. Extensive surgical resection was not considered for the patients in this series because either it would not affect the natural history of the presumed disease or surgical morbidity would be too high.
Our small sample size also limited detailed statistical analysis and generalizability of the technique. Furthermore, postoperative MRIs were not routinely obtained in the study to evaluate for extent of resection and/or subclinical injury to the surrounding brain tissue using T2 fluid-attenuated inversion recovery and diffusion-weighted image sequences. We typically only obtained postoperative head CTs. However, no patients incurred new deficits or significant parenchymal hematomas, symptomatic strokes, or malignant edema. Our short follow-up period also limits discussion of possible long-term effects and neurologic deficits. Future studies with larger cohorts may better allow the expansion of this technique. Nonetheless, we believe this technique provides a successful means of performing biopsies of deep-seated brain lesions.
Conclusion
Diagnosing brain lesions is critical for guiding potential adjuvant therapies. The gold standard for diagnosing these lesions is to obtain tissue for pathologic evaluation. This can be done either via needle biopsy or open biopsies through craniotomies. When surgical resection is not possible or required, we report the efficacy of using a tubular retractor system with exoscopic visualization for safe access of deepseated lesions to provide adequate tissue for diagnosis, tissue banking, and molecular evaluation.
